Express & Expedited Shipping Service
USD $131.99
AustraliaGO Healthy Manuka Honey UMF 5+ (MGO 80+) is a premium quality honey sourced from the pristine landscapes of New Zealand. This honey is renowned for its unique properties and is certified with a UMF (Unique Manuka Factor) rating of 5+, indicating its purity and quality.
UMF 5+ signifies that the honey has been independently tested and verified for its unique Manuka properties. The MGO (methylglyoxal) content of 80+ further confirms its authenticity and efficacy, ensuring that you are consuming genuine Manuka honey.
GO Healthy Manuka Honey is celebrated for its potential health benefits. It may support digestive health, promote natural healing, and enhance overall well-being. Its natural antibacterial properties make it a popular choice for those seeking a healthful addition to their diet.
This versatile honey can be consumed directly by the spoonful, added to teas and smoothies, or used as a natural sweetener in cooking and baking. It can also be applied topically to support skin health.
GO Healthy Manuka Honey is generally safe for most people. However, it is not recommended for infants under one year of age. Those with specific allergies or medical conditions should consult a healthcare professional before use.
Due to local regulations and restrictions, GO Healthy Manuka Honey is not available for sale in Western Australia. We recommend checking local guidelines if you have any questions regarding availability in your area.
To maintain its quality and efficacy, store GO Healthy Manuka Honey in a cool, dry place away from direct sunlight. Avoid refrigeration, as this can cause the honey to crystallize.
Health Guides
Nov 03, 2026
Insulin injection sites should rotate with every dose, using a different point within a planned body area. Home injections go into subcutaneous fat under the skin, not into muscle or a vein. Repeated injections into one spot can cause lipohypertrophy, a fatty lump that makes the insulin absorption r
Nov 02, 2026
ADHD medication monitoring tracks blood pressure, heart rate, body mass, appetite and sleep before treatment, during dose adjustments and throughout long-term care. For adults, NICE recommends pulse and blood pressure checks before and after each dose change, then every six months. The aim is to pre
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 31, 2026
Whether to repeat a dose of an oral medication depends on the medicine, formulation, and elapsed time. Vomiting within 15 minutes or seeing an intact tablet can justify considering a replacement; after an hour, another dose is usually unnecessary. These are general timing guides, not permission to r
Oct 30, 2026
Tacrolimus monitoring measures the tacrolimus level in whole blood to help balance organ rejection prevention against drug-related toxic effects. The result is useful only when interpreted against the dose and formulation. A routine trough sample is collected immediately before the next dose, usuall
Oct 28, 2026
Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration
Oct 26, 2026
Amlodipine widens small arteries more than veins, pushing fluid into surrounding tissues. Ankle swelling is one of the recognized side effects of this medicine. Mild swelling in both ankles is common, but new or worsening symptoms deserve medical review. The key distinction is where the swelling occ
Oct 22, 2026
Parkinson's disease medications improve movement by replacing dopamine, stimulating its receptors, or slowing its breakdown. Carbidopa-levodopa remains the most effective treatment for movement symptoms, while other medicines address milder symptoms, wearing-off, or involuntary movements. Treatment
Oct 20, 2026
Methimazole for hyperthyroidism reduces excess thyroid hormone production without destroying the thyroid gland. Treatment usually starts with a higher dose, followed by blood-test-guided reductions as hormone levels return to normal. This guide to methimazole hyperthyroidism treatment covers testing
Oct 19, 2026
Atrial fibrillation medications address three goals: rate control for a fast heart rate, rhythm control for an abnormal rhythm, and stroke prevention with anticoagulants that reduce blood clots. For atrial fibrillation, the regimen depends on stroke risk, heart and kidney function, and other prescri
